ABCG2 and hyperuricemia: Benzbromarone also inhibits urate transport via ABCG2, as does febuxostat (12), suggesting that URAT1 inhibitors are more potent in lowering serum urate than XOR inhibitors in hyperuricemia of reduced urate excretion type.